glp 1 agonist euglycemic dka Linking To And Embedding EM Note's "Euglycemic DKA" Beyond Weight Loss: ED Implications
Description
Obesity and Type 2 Diabetes has an increasing prevalence worldwide, presenting a major health challenge
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk
For Indian patients, this is a major development
What are payers doing to manage GLP-1 coverage and cost, and how can Rx Savings Solutions advance their strategies?
